Xeno Transplants Corporation
XENO · OTC
6/30/2007 | 6/30/2006 | 6/30/2005 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $128 | $47 | $33 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | -$256 | -$93 | -$65 |
| Operating Expenses | -$128 | -$47 | -$33 |
| Operating Income | $128 | $47 | $33 |
| % Margin | – | – | – |
| Other Income/Exp. Net | -$256 | -$93 | -$65 |
| Pre-Tax Income | -$128 | -$47 | -$33 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$128 | -$47 | -$33 |
| % Margin | – | – | – |
| EPS | -0.004 | -0.01 | -0.005 |
| % Growth | 61% | -96.1% | – |
| EPS Diluted | -0.004 | -0.01 | -0.005 |
| Weighted Avg Shares Out | 33,182 | 9,168 | 6,474 |
| Weighted Avg Shares Out Dil | 33,182 | 9,168 | 6,474 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$128 | -$46 | -$33 |
| % Margin | – | – | – |